https://www.selleckchem.com/pr....oducts/Cyclosporin-A
v. therapy (risk ratio [RR] 0.38, 95% confidence interval, confidence interval [CI] 0.20-0.74; p = 0.004; I2 0%). IE relapse rates were similar (RR 0.63, 95% CI 0.29-1.37; p = 0.24; I2 0%). CONCLUSION Data comparing POT with standard care in IE is limited and to date only one sufficiently powered stand-alone trial exists to support its use. In this meta-analysis POT was non-inferior to i.v. therapy with respect to mortality and IE relapse in non-critically ill patients suffering from both left-sided and right-sided
Like
Comment
Share
